Carcinomas invasores triples negativosde la glándula mamaria: incidencia y características clínico-patológicas Triple-Negative Invasive Breast Carcinoma: Incidence and Clinical - Pathological Characteristics

Carcinomas invasores triples negativosde la glándula mamaria: incidencia y características clínico-patológicas Triple-Negative Invasive Breast Carcinoma: Incidence and Clinical - Pathological Characteristics

Justificación y objetivo: El comportamiento epidemiológico de los tumores malignos del país ha presentado un cambio en los últimos años; el cáncer de mama ha aumentado su incidencia hasta colocarse como el segundo tumor maligno más frecuente en la mujer y el primero en mortalidad. Este tipo de tumor...

Full description

Bibliographic Details
Main Authors:	José L Quirós-Alpízar, Yendry Jiménez-Rodríguez, Ernesto Jiménez-Montero, Melissa Monge-Víquez, Lizbeth Salazar-Sánchez
Format:	Article
Language:	English
Published:	Colegio de Médicos y Cirujanos de Costa Rica 2010-06-01
Series:	Acta Médica Costarricense
Subjects:	cáncer de mama triple negativo inmunohistoquímica receptores de estrógenos y progesterona receptor 2 del factor humano de crecimiento epidermal (HER-2) breast cancer triple-negative immunohistochemistry progesterone and estrogen receptors HER-2
Online Access:	http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0001-60022010000200006

Similar Items

Carcinomas invasores triples negativosde la glándula mamaria: incidencia y características clínico-patológicas
by: José L Quirós-Alpízar, et al.
Published: (2010-06-01)

Predictive factors of breast cancer evaluated by immunohistochemistry Fatores preditivos do câncer de mama avaliados pela imuno-histoqu��mica
by: Helenice Gobbi, et al.
Published: (2008-04-01)

Triple Negative Breast Cancer-An Overview and Review of Literature
by: Amit Gupta
Published: (2013-02-01)

Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda
by: Mlole AT, et al.
Published: (2020-11-01)

Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: A Comparative Study
by: Leila Rahmani, et al.
Published: (2012-03-01)

Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: A Comparative Study
by: Tahere Zarouk Ahimahalle, et al.
Published: (2012-01-01)

Clinical characteristics of triple negative breast cancer in Egyptian women: a hospital-based experience
by: Nivine Gado, et al.
Published: (2016-06-01)

Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers
by: M. Ángeles López-García, et al.
Published: (2020-06-01)

Clinicopathological Features of Triple Negative Breast Carcinoma
by: Gowry Maram Reddy, et al.
Published: (2017-01-01)

A Comparison of Clinical Features, Pathology and Outcomes in Various Subtypes of Breast Cancer in Indian Women
by: Anupama Mane, et al.
Published: (2015-09-01)

Carcinoma metaplásico de mama. Revisión de 6 casos diagnosticados en el Hospital México, durante el período 2000-2006
by: Ángel Lazo-Valladares, et al.
Published: (2007-10-01)

Current approaches in treatment of triple-negative breast cancer
by: Hanan Ahmed Wahba, et al.
Published: (2015-06-01)

Carcinoma metaplásico de mama. Revisión de 6 casos diagnosticados en el Hospital México, durante el período 2000-2006
by: Ángel Lazo-Valladares, et al.
Published: (2007-10-01)

Detección del receptor tipo 2 del factor de crecimiento epidérmico humano (her2/neu): inmunohistoquímica en carcinomas de mama
by: José Luis Quirós-Alpízar, et al.
Published: (2015-03-01)

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
by: Fabio Conforti, et al.
Published: (2021-10-01)

The susceptibility to infection by Leishmania panamensis and the sensitivity to drugs differ according to the macrophage type Expresión de los receptores hormonales (RE/RP) y sobreexpresión de la proteína HER-2/neu en carcinoma ductal infiltrante
by: Olga T. Anteliz B., et al.
Published: (2011-08-01)

Epidemiological and pathological characteristics of postsurgical cases of invasive breast cancer among ethnicities of Iran in 2018: A single center cross-sectional study
by: Sayad Soheila, et al.
Published: (2020-01-01)

Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape
by: Garbar C, et al.
Published: (2018-05-01)

Immunohistoochemical evaluation of GATA-3, pAKT and Ki-67 in triple negative breast carcinoma
by: Gopi Aryal, et al.
Published: (2017-09-01)

Receptores de progesterona y grado histológico del cáncer ductal de glándula mamaria
by: Juan Carlos Bonilla, et al.
Published: (2007-06-01)

Receptores de progesterona en meningioma.
by: Herminio Ojeda Di Ninno, et al.
Published: (1995-04-01)

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
by: Ishita Gupta, et al.
Published: (2020-09-01)

The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
by: Hamid Maadi, et al.
Published: (2018-03-01)

Estrogen Receptors, Progesterone Receptors and their Correlation with respect to HER-2/neu Status, Histological Grade, Size of Lesion, Lymph node Metastasis, Lymphovascular Involvement and Age in Breast Cancer patients in a hospital in north India
by: Mushood G. Nabi
Published: (2016-01-01)

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
by: Tejaswini P. Reddy, et al.
Published: (2020-05-01)

Análisis de los factores inmunohistopatológicos (receptores hormonales, estrógenos, progesterona y ERB-2) asociados al pronóstico del cáncer de mama en la población de Barranquilla (2004- 2005)
by: Luz Alba Silvera Arenas, et al.
Published: (2007-01-01)

Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone
by: Jason A. Mouabbi, et al.
Published: (2021-07-01)

EFFECT OF AGE ON PROGNOSIS IN DIFFERENT MOLECULAR SUBTYPES OF FEMALE BREAST CARCINOMA
by: Naveed Sharif, et al.
Published: (2015-09-01)

Epstein-Barr Virus is Associated With Aggressive Subtypes of Invasive Ductal Carcinoma of Breast (Her2+/ER- and Triple Negative) and With Nuclear Expression of NF?B p50
by: Ashley James Ballard
Published: (2018-06-01)

Cáncer gástrico: sobreexpresión de HER2 por inmunohistoquímica hospital de san José, Bogotá DC, 2005 a 2009
by: María del Pilar Archila, et al.
Published: (2013-03-01)

Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
by: Jinqian Mao, et al.
Published: (2021-04-01)

Expressão gênica dos REα, REβ e PR em tumores mamários de cadelas por meio do q-PCR
by: R.S. Ramos, et al.
Published: (2012-12-01)

Ciblage de l'entité HER2/HER3 par des anticorps monoclonaux pour le traitement des cancers du pancréas exprimant faiblement HER2.
by: Thomas, Gaëlle
Published: (2013)

Distinct Microbial Signatures Associated With Different Breast Cancer Types
by: Sagarika Banerjee, et al.
Published: (2018-05-01)

Interaction between HER-2 and Hormone Receptors in Breast Cancer
by: Majid Moghadaszadeh, et al.
Published: (2010-12-01)

Interaction between HER-2 and Hormone Receptors in Breast Cancer
by: Majid Moghadaszadeh, et al.
Published: (2010-10-01)

Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer
by: Iveta Kolarova, et al.
Published: (2019-12-01)

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
by: Amany Salama, et al.
Published: (2019-05-01)

Molecular phenotypes of ductal carcinoma-in-situ and invasive ductal carcinoma: A comparative study
by: Shilpa Gupta, et al.
Published: (2012-01-01)

IMMUNOHISTOCHEMICAL EXPRESSION OF ANDROGEN RECEPTOR IN TRIPLE NEGATIVE BREAST CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY, RAWALPINDI
by: Amna Ameer, et al.
Published: (2021-02-01)